Rob J Fredericksen, Rodney Perkins, Clare E Brown, Chase Cannon, Carolina Lopez, Alison Cohee, Julia Cook Dombrowski, Stephanie Cohen, Cheryl Malinski, Minh Powell, Anne F Luetkemeyer, Connie Celum, Katerina Christopoulos
Doxycycline postexposure prophylaxis (doxy-PEP) reduces sexually transmitted infections (STIs) in men who have sex with men (MSM) and transgender women (TGW). In a clinical trial of doxy-PEP, we sought to assess acceptability, impact, and meaning of doxy-PEP use among MSM/TGW. We conducted semistructured, in-depth 1:1 interviews with MSM and TGW enrolled in the intervention arm of the Doxy-PEP study. We queried motivations for and meaning of use, attitudes, beliefs, adherence, effect on sexual behaviors, and partner, community, and structural factors related to use...
April 2024: AIDS Patient Care and STDs